In addition to intellectual disability, individuals with Down syndrome (DS) exhibit dementia by the third or fourth decade of life, due to the early onset of neuropathological changes typical of Alzheimer's disease (AD). Deficient ontogenetic neurogenesis contributes to the brain hypoplasia and hypocellularity evident in fetuses and children with DS. A murine model of DS and AD (the Ts65Dn mouse) exhibits key features of these disorders, notably deficient ontogenetic neurogenesis, degeneration of basal forebrain cholinergic neurons (BFCNs), and cognitive deficits. Adult hippocampal (HP) neurogenesis is also deficient in Ts65Dn mice and may contribute to the observed cognitive dysfunction. Herein, we demonstrate that supplementing the maternal diet with additional choline (approximately 4.5 times the amount in normal rodent chow) dramatically improved the performance of the adult trisomic offspring in a radial arm water maze task. Ts65Dn offspring of choline-supplemented dams performed significantly better than unsupplemented Ts65Dn mice. Furthermore, adult hippocampal neurogenesis was partially normalized in the maternal choline supplemented (MCS) trisomic offspring relative to their unsupplemented counterparts. A significant correlation was observed between adult hippocampal neurogenesis and performance in the water maze, suggesting that the increased neurogenesis seen in the supplemented trisomic mice contributed functionally to their improved spatial cognition. These findings suggest that supplementing the maternal diet with additional choline has significant translational potential for DS.
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Introduction
Down syndrome (DS) is the most common known cause of intellectual disability, affecting 1 in 700-1000 births. This disorder is caused by triplication of human chromosome 21(HSA21) due to nondysjunction during meiosis. In addition to intellectual disability, individuals with DS generally develop dementia by the third decade of life (Lai and Williams, 1989; Mann, 1988; Visser et al., 1997; Wisniewski et al., 1985a Wisniewski et al., , 1985b due to the onset of Alzheimer's disease (AD)-like neuropathology, including atrophy of basal forebrain cholinergic neurons (BFCNs) (Isacson et al., 2002; Sendera et al., 2000; Whitehouse et al., 1982) , and formation of neuritic plaques and neurofibrillary tangles (Wisniewski et al., 1985a) .
Currently there are no clinically approved treatments for either intellectual disability or dementia in DS. The development of a mouse model of DS provides a tool to investigate the pathogenic process(es) underlying this disorder and consequently provide effective therapies. A segmental trisomy mouse model of DS, the Ts65Dn mouse (Davisson et al., 1990; Holtzman et al., 1996) , is trisomic for the distal portion of mouse chromosome 16 (MMU16), which contains over 100 genes orthologous to those on HSA21 (Patterson and Costa, 2005; Sturgeon and Gardiner, 2011) . Ts65Dn mice survive to adulthood and exhibit many morphological, biochemical, and transcriptional changes seen in 
